Pitt Shield

Optimization of MR-ARFI for Human Transcranial Focused Ultrasound.

Authors: Mohammadjavadi M, Ash RT, Glover GH, Pauly KB

Magnetic resonance acoustic radiation force imaging (MR-ARFI) is an exceptionally promising technique to non-invasively confirm targeting accuracy and estimate exposure of low-intensity transcranial focused ultrasound stimulation. MR-ARFI uses magnetic field motion encoding gradients to visualize the MR phase changes generated by microscopic displacements at the ultrasound focus. Implementing MR-ARFI in the human central nervous system has been hindered by 1) phase distortion caused by subject motion, and 2) insufficient signal-to-noise ratio at low (<1.0 MPa) ultrasound pressures. The purpose of this study was to optimize human MR-ARFI to allow reduced ultrasound exposure while at the same time being robust to bulk and physiological motion. We demonstrate that a time series of single-shot spiral acquisitions, while triggering ultrasound on and off in blocks, provides ARFI maps that with correction are largely immune to bulk and pulsatile brain motion. Furthermore, the time series approach allows for a reduction in ultrasound exposure per slice while improving motion robustness with reduced scan time. The focused ultrasound beam can be visualized in an 80 second scan with our protocol, enabling iteration for image-guided targeting. We demonstrated robust ARFI signals at the expected target in 4 participants. Our results provide persuasive proof-of-principle that MR-ARFI can be used as a tool to guide ultrasound-based precision neural circuit therapeutics.

Introduction

Purpose Transcranial ultrasound stimulation
Study Objective To optimize human MR-ARFI to allow reduced ultrasound exposure while at the same time being robust to bulk and physiological motion.
Animal model / Human subject Homo sapiens (human participants), strain: N/A, age: not reported, sex: not reported (4 participants)
Disease model healthy
MRI or image guidance method MRI-guided (MR-ARFI: magnetic resonance acoustic radiation force imaging) using time-series single-shot spiral acquisitions with block-triggered ultrasound to visualize the focused ultrasound beam and confirm targeting.
Targeted brain region(s) Not Specified In Provided Text
Cargo name and characteristics Low-intensity transcranial focused ultrasound stimulation (focused ultrasound beam used for MR-ARFI), acoustic agent producing microscopic tissue displacements; ultrasound pressures referenced <1.0 MPa; no molecular cargo or biological vector described.
Route of administration Not applicable — no drug or cargo was administered; intervention was transcranial (non-invasive focused ultrasound stimulation)

Outcomes and Safety

Summary of Outcomes Implementation of a time-series single-shot spiral MR-ARFI protocol with block-triggered ultrasound produced robust visualization of the focused ultrasound beam in human brain, yielding clear ARFI signals at the expected target in 4 participants. The method was largely immune to bulk and pulsatile brain motion after correction, enabled reduction of ultrasound exposure per slice, shortened scan time (focus visualized in ~80 s), and thus permits rapid, motion-robust, low-exposure image-guided targeting for ultrasound-based precision neural circuit interventions.
Duration of biological effect 80 seconds
Safety-related matter Mentions of safety-related terms: estimation of exposure for low-intensity transcranial focused ultrasound; reference to low (<1.0 MPa) ultrasound pressures; goal to allow reduced ultrasound exposure and report of a reduction in ultrasound exposure per slice. The abstract contains no mention of tissue damage, adverse effects, or safety incidents; no adverse events reported in the 4 participants.

Brain Region

Ultrasound Parameters

FUS Frequency Not specified in the provided text
FUS Intensity <1.0 MPa
FUS Pressure <1.0 MPa
FUS Mode pulsed
Pulse duration Not reported in provided text
Duration of a single FUS session 80 seconds
Focal Characteristics No focal size, depth, or beam diameter details provided in the paper text.
Treatment frequency single session

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search